Bank of New York Mellon
SANA icon

Bank of New York Mellon’s Sana Biotechnology SANA Stock Holding History

Bank of New York Mellon’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67M Buy
477,542
+34,938
+8% +$113K ﹤0.01% 3061
2026
Q1 		$1.27M Sell
442,604
-14,622
-3% -$57.6K ﹤0.01% 3063
2025
Q4 		$1.86M Buy
457,226
+51,565
+13% +$231K ﹤0.01% 2883
2025
Q3 		$1.44M Buy
405,661
+10,671
+3% +$38.6K ﹤0.01% 2997
2025
Q2 		$1.08M Buy
394,990
+50,932
+15% +$105K ﹤0.01% 3093
2025
Q1 		$578K Buy
344,058
+7,230
+2% +$20.2K ﹤0.01% 3380
2024
Q4 		$549K Buy
336,828
+9,905
+3% +$29.5K ﹤0.01% 3474
2024
Q3 		$1.36M Sell
326,923
-104,821
-24% -$551K ﹤0.01% 2961
2024
Q2 		$2.36M Buy
431,744
+90,423
+26% +$721K ﹤0.01% 2707
2024
Q1 		$3.41M Sell
341,321
-21,691
-6% -$162K ﹤0.01% 2501
2023
Q4 		$1.48M Sell
363,012
-6,865
-2% -$25.3K ﹤0.01% 2975
2023
Q3 		$1.43M Buy
369,877
+742
+0.2% +$3.99K ﹤0.01% 2983
2023
Q2 		$2.2M Buy
369,135
+9,880
+3% +$56.9K ﹤0.01% 2781
2023
Q1 		$1.17M Sell
359,255
-4,902
-1% -$19.6K ﹤0.01% 3069
2022
Q4 		$1.44M Sell
364,157
-7,507
-2% -$36.7K ﹤0.01% 3021
2022
Q3 		$2.23M Buy
371,664
+62,182
+20% +$449K ﹤0.01% 2776
2022
Q2 		$1.99M Sell
309,482
-45,960
-13% -$293K ﹤0.01% 2838
2022
Q1 		$2.94M Sell
355,442
-1,369
-0.4% -$11.1K ﹤0.01% 2714
2021
Q4 		$5.52M Buy
356,811
+34,533
+11% +$666K ﹤0.01% 2413
2021
Q3 		$7.26M Buy
322,278
+234,977
+269% +$4.93M ﹤0.01% 2301
2021
Q2 		$1.72M Buy
87,301
+38,196
+78% +$866K ﹤0.01% 3098
2021
Q1 		$1.64M Buy
+49,105
New +$1.6M ﹤0.01% 3039

Other funds holding SANA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Bank of New York Mellon's SANA Position: Q2 2026 in Review

Bank of New York Mellon increased its Sana Biotechnology (SANA) stake by 7.9% in Q2 2026, buying an estimated $113K and bringing the position to 477,542 shares worth $1.67M. The position accounts for ﹤0.01% of the portfolio, ranked #3061.

Bank of New York Mellon first reported a position in SANA in Q1 2021 and has held it in 22 quarters since. The position peaked at $7.26M in Q3 2021. 101 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Bank of New York Mellon held 477,542 shares of Sana Biotechnology worth $1.67M as of Q2 2026.
  • Bank of New York Mellon bought 34,938 Sana Biotechnology shares in Q2 2026, an estimated $113K.
  • Sana Biotechnology made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3061 holding.
  • Bank of New York Mellon first reported a position in Sana Biotechnology in Q1 2021 and has held it in 22 quarters since.
  • Bank of New York Mellon's Sana Biotechnology position peaked at $7.26M in Q3 2021.
  • 101 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.